Table 9.
Reference | Type of study | Test system | Dose |
---|---|---|---|
Unpublished Study, LPT No. 35908 (Parschat et al., 2020) |
Bacterial reverse mutation test (GLP, OECD TG 471) |
Salmonella Typhimurium TA98, TA100, TA102, TA1535 and TA1537 | 0.8–90 mg 3‐FL/plate (absence and presence of S9 mix) |
Unpublished Study, LPT No. 35909 (Parschat et al., 2020) |
In vitro mammalian cell micronucleus test in human peripheral blood lymphocytes (GLP, OECD TG 487) | Human peripheral blood lymphocytes | 1.2–9.6 mg 3‐FL/mL for 4 or 24 h (absence and presence of S9 mix) |
Unpublished study, LPT No. 35504 (Parschat et al., 2020) |
7‐day repeated dose oral toxicity study (pilot study) | SD rats (females only) | Dietary exposure ranging from 6.7 to 13.7 g/kg bw/day (mean 3‐FL intake: 1.07–2.19 g/kg bw/day) |
Unpublished Study, LPT No. 35907 (Parschat et al., 2020) |
90‐day repeated dose oral toxicity study (GLP, OECD TG 408, limit test) | SD rats | Overall dietary exposure to 3‐FL of 16% of the mixture (mean intake of 0.91 and 1.12 g 3‐FL/kg bw/day in males and females, respectively) |